Blood transfusions for sickle cell disease
Treatment Overview
During a blood transfusion, a person (the recipient) receives healthy blood from another person (the donor). The donated blood is carefully screened for diseases before it is used. Before receiving a blood transfusion, the recipient's blood is analyzed closely (using blood type) to make sure the donor blood is a close match to the recipient's.
Blood is transfused into an arm vein slowly over 1 to 4 hours (except in an emergency when blood is transfused more quickly).
Blood transfusions can:
- Treat a sudden or short-term condition related to sickle cell disease.
- Treat severe complications of sickle cell disease.
- Prevent complications of sickle cell disease.
- Lower the risk of stroke in infants and children.
Blood transfusions aren't usually used to treat uncomplicated painful events or mild to moderate anemia.
What To Expect After Treatment
Following a blood transfusion, health professionals keep a close watch on the person for any negative reactions.
- A transfusion reaction, resulting from mismatched blood type, may occur immediately or days later (5 to 20 days after transfusion). An acute transfusion reaction ranges from mild (fever, chills, and rash) to severe (shock, severe anemia, painful event and death).
- A person receiving repeat blood transfusions may develop antibodies to the donor blood (called alloimmunization). Alloimmunization makes repeated transfusions more difficult. Up to 29% of people with sickle cell disease who receive blood transfusions develop alloimmunization.1
Hospital staff will also check for iron buildup in the body (iron overload). This can develop when a person receives many transfusions.
Why It Is Done
A blood transfusion lowers the amount of hemoglobin S red blood cells in the body. When there are fewer sickled hemoglobin S cells in the bloodstream, they are less likely to build up and block blood vessels.
Blood transfusion also increases the number of normal red blood cells in the body, increasing the supply of oxygen to the body.
Anemia
Some sudden complications of sickle cell disease cause the body's red blood cell count to drop to life-threatening levels (severe anemia). When severe, these conditions (including splenic sequestration, acute chest syndrome, and aplastic crisis) can be fatal if not treated with blood transfusions.
Chronic severe anemia from kidney failure may need treatment with periodic blood transfusions.
Surgery
After undergoing general anesthesia and surgery, people with sickle cell disease are at risk for sickling-related problems and acute chest syndrome. Blood transfusions before surgery can prevent or treat these complications.
Red blood cell sickling-related complications (vaso-occlusion)
Blood transfusions can treat acute chest syndrome and leg ulcers.
Periodic blood transfusions may help prevent strokes in infants, children, and teens who previously had a stroke or are at high risk for a first stroke.1
How Well It Works
Blood transfusion is currently the single most effective and proven treatment for some severe complications of sickle cell disease.2
Blood transfusions reduce the risk of some complications of sickle cell disease and improve symptoms of severe anemia. Using repeat blood transfusions for 3 to 5 years reduces the number of repeat strokes in children who have had a stroke.
Risks
A person receiving many blood transfusions will gradually collect too much iron in the body (iron overload). Very high levels of iron can lead to hemochromatosis, which can be fatal if untreated.
After 10 to 20 blood transfusions, iron chelation treatment can help rid the body of excess iron.
It's remotely possible that donor blood may be contaminated with an infectious disease (such as HIV or hepatitis). However, donated blood is carefully screened for diseases before it is used.3
What To Think About
If you have repeated blood transfusions, you'll have routine testing for iron buildup in your body.
Though blood transfusions are an effective treatment for sickle cell disease complications, they are only used selectively. The risks of hemochromatosis and alloimmunization from repeat transfusions makes this procedure more suitable for severe and high-risk conditions.
Doctors and researchers continue to weigh the benefits against the risks of preventive blood transfusions. Using repeat blood transfusions for 3 to 5 years reduces the number of strokes in children. Usually, if a child has a stroke, that child is 50% more likely to have another within 3 years. But if the child has transfusion treatment, that risk is lowered to 10%.4
Complete the special treatment information form (PDF)
(What is a PDF document?) to help you understand this treatment.
| Author: | Debby Golonka, MPH Carrie Henley | Last Updated: March 23, 2007 |
| Medical Review: | Anne C. Poinier, MD - Internal Medicine Donald Sproule, MD, CM, CCFP, FCFP - Family Medicine Martin Steinberg, MD - Hematology | |
 | ||
| |
| Topic Contents | |
| Treatment Overview | |
| What To Expect After Treatment | |
| Why It Is Done | |
| How Well It Works | |
| Risks | |
| What To Think About | |
| References | |